Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis ; volume:22 ; number:1 ; day:7 ; month:6 ; year:2022 ; pages:1-9 ; date:12.2022
BMC neurology ; 22, Heft 1 (7.6.2022), 1-9, 12.2022
- Urheber
-
Fox, Robert J.
Mehta, Rina
Pham, Timothy
Park, Julie
Wilson, Kathleen
Bonafede, Machaon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-022-02738-7
- URN
-
urn:nbn:de:101:1-2022080419272414672521
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fox, Robert J.
- Mehta, Rina
- Pham, Timothy
- Park, Julie
- Wilson, Kathleen
- Bonafede, Machaon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Claims for disease-modifying therapy by Alberta non-insured health benefits clients
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
Current Disease-Modifying Therapies in Multiple Sclerosis
Early high-efficacy disease-modifying therapy in multiple sclerosis: a 4-year real-world study
Disease-modifying treatments in Alzheimer’s disease
Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Current experimental disease-modifying therapeutics for multiple system atrophy
Lithium as a disease-modifying agent for prion diseases
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Claims for disease-modifying therapy by Alberta non-insured health benefits clients
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
Current Disease-Modifying Therapies in Multiple Sclerosis
Early high-efficacy disease-modifying therapy in multiple sclerosis: a 4-year real-world study
Disease-modifying treatments in Alzheimer’s disease
Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Current experimental disease-modifying therapeutics for multiple system atrophy
Lithium as a disease-modifying agent for prion diseases
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Claims for disease-modifying therapy by Alberta non-insured health benefits clients
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
Current Disease-Modifying Therapies in Multiple Sclerosis
Early high-efficacy disease-modifying therapy in multiple sclerosis: a 4-year real-world study
Disease-modifying treatments in Alzheimer’s disease
Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Current experimental disease-modifying therapeutics for multiple system atrophy
Lithium as a disease-modifying agent for prion diseases
Jellyfish mucin may have potential disease-modifying effects on osteoarthritis